Absher Wealth Management’s Novo Nordisk NVO Stock Holding History

Absher Wealth Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-9,476	Closed	-$526K	–	52
2022 Q1	$526K	Sell	9,476 -2,962	-24%	-$152K	0.09%	47
2021 Q4	$697K	Sell	12,438 -1,048	-8%	-$56.8K	0.12%	45
2021 Q3	$647K	Sell	13,486 -2,266	-14%	-$110K	0.12%	45
2021 Q2	$660K	Buy	15,752 +720	+5%	+$27.9K	0.12%	45
2021 Q1	$507K	Buy	15,032 +2,004	+15%	+$71.4K	0.1%	50
2020 Q4	$455K	Buy	13,028 +724	+6%	+$25K	0.1%	48
2020 Q3	$427K	Buy	12,304 +70	+0.6%	+$2.33K	0.1%	48
2020 Q2	$401K	Sell	12,234 -4,852	-28%	-$155K	0.1%	51
2020 Q1	$514K	Buy	17,086 +136	+0.8%	+$4.05K	0.16%	42
2019 Q4	$511K	Buy	+16,950	New	+$469K	0.13%	42

Other funds holding NVO

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Absher Wealth Management's NVO Position: Q2 2022 in Review

Absher Wealth Management sold out of Novo Nordisk (NVO) in Q2 2022, closing a stake of 9,476 shares — an estimated $526K sold.

Absher Wealth Management first reported a position in NVO in Q4 2019 and held it in 10 quarters. The position peaked at $697K in Q4 2021. 933 funds tracked by Wall St. Rank hold NVO as of Q2 2022.

Absher Wealth Management reported no remaining Novo Nordisk position as of Q2 2022 after selling out during the quarter.
Absher Wealth Management sold 9,476 Novo Nordisk shares in Q2 2022, an estimated $526K.
Absher Wealth Management first reported a position in Novo Nordisk in Q4 2019 and held it in 10 quarters.
Absher Wealth Management's Novo Nordisk position peaked at $697K in Q4 2021.
933 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2022.

Based on Absher Wealth Management's 13F filing for Q2 2022, filed 25 Jul 2022.